Related Experiment Video
Updated: Jun 19, 2025

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
Published on: May 16, 2016
Inflammation unites diverse acute and chronic diseases
Peter Libby1, Robin Smith2, Eric J Rubin3
1Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Inflammation and immunity are key to many diseases. Recognizing shared inflammatory mechanisms across diverse conditions can accelerate therapeutic innovation and improve public health outcomes.
Area of Science:
- Immunology
- Pathology
- Translational Medicine
Background:
- Inflammation and immunity are central to numerous acute and chronic diseases, representing significant global health challenges.
- Current therapeutic strategies often focus narrowly on single diseases, potentially limiting innovation.
- A deeper understanding of shared inflammatory pathways is crucial for advancing clinical translation.
Purpose of the Study:
- To review and highlight common inflammatory and immune mechanisms across a spectrum of diseases.
- To identify opportunities for synergy and collaboration among scientific, medical, and pharmaceutical sectors.
- To underscore the potential of targeting shared inflammation pathways for novel therapeutic development.
Main Methods:
- A multidisciplinary think tank convened to analyze shared inflammatory mechanisms.
- Review of existing literature and consensus building on commonalities in disease pathogenesis.
- Exploration of how inflammation contributes to diverse conditions, aging, and healthspan.
Main Results:
- Shared inflammatory mechanisms were identified across seemingly disparate diseases, including infection, cardiovascular, pulmonary, rheumatological, neurological (dementia), oncological, and aging processes.
- Overlapping pathogenesis highlights significant commonalities in disease etiology.
- Opportunities for consolidating research efforts and reducing duplication were outlined.
Conclusions:
- Recognizing shared inflammatory pathways can simplify the understanding of complex diseases for clinicians.
- Inflammation emerges as a unifying therapeutic target, with novel therapies becoming increasingly actionable.
- Cross-disciplinary collaboration, driven by an appreciation of commonalities, can accelerate progress in inflammation research.
More Related Videos
Related Concept Videos
Inflammation
Inflammatory Response I: Vascular and Cellular
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

